Our ambition is to be a catalyst for positive change. Our continued investment in our planet supports our purpose to reimagine medicine to improve and extend people’s lives. It is also a way to build trust with society, if our actions are guided by a commitment to transparency and creating enduring change.

Our Commitments

Silouhette of a group if business people


We will encourage associates across our operations to adopt an environmental sustainability mindset.

Silhouette of a woman holding the hand of a child


We will work to understand how a changing climate will impact people's health and deliver environmentally sustainable medicines.

Blue globe icon


We will minimize the impact of our actions on the planet and invest in environmental solutions that also protect biodiversity.


Our Strategy and Targets

We aim to drive sustainability through our own operations, as well as those of our suppliers, and we have set ambitious targets to minimize our impacts on climate, waste and water.

In 2021, we committed to becoming Net Zero by 2040. We are currently in the process of aligning our strategy and targets to the new Science Based Targets (SBT) Net Zero Standard published in October 2021. 

Our 2022 Performance


reduction in greenhouse gas emissions (Scope 1 and 2) vs. 2016 baseline


reduction in our own operations vs. 2016 baseline


reduction in waste disposal vs. 2016 baseline

Environmental sustainability reporting

We take our responsibility to protect the environment seriously. We publish several key pieces of information about our efforts to reduce our impacts on the environment.

Novartis in Society Integrated Report 2022

The Novartis in Society Integrated Report covers our business, strategy and performance, including on environmental, social and governance topics. 

View the interactive digital version

View the full report in English (PDF 8.8 MB)

Novartis Environmental Performance Indicator 2019-2021

Environmental data is collected and reviewed on a quarterly basis. This data table was published with actual data in H2 2022. 

Download (PDF 0.1 MB)